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The title compounds were prepared from ethyl cyanoacetate by the four-step procedure of conversion into the 
corresponding 2-hydroxyimino-derivative, transesterification with either hexadecanol or cyclohexanol, catalytic 
hydrogenation of the respective products to afford the diamino-dihydrochlorides, and complex formation of the 
latter pair with potassium tetrachloroplatinate. Assignment of the structures of the cis-platinum complexes was 
confirmed by infrared spectrometry. 
Die titelverbindings is vanaf etielsianoasetaat deur middel van 'n vierstapprosedure berei. Die uitgangstof is na die 
ooreenstemmende 2-hidroksi-imino-derivaat omgeskakel, wat dan met of heksadekanol of sikloheksanol 
getransesterifiseer is. Daaropvolgende katalitiese hidrogenering van die onderskeie produkte het die diamino-
dihidrochloriede gelewer, wat met kalium-tetrachloroplatinaat na die gesogte komplekse omgeskakel is. Die 
strukture van die cis-platinumkomplekse is deur infrarooispektrometrie vasgestel. 
'To whom correspondence should be addressed 
The platinum complex, dichlorodiammineplatinum(II) 
('cisplatin') (1), is known l for its antitumour activity, although 
its toxicity detracts from its value as a chemotherapeutic 
drug in the treatment of cancer. Certain derivatives of the 
compound in which the two ammine groups form part of a 
2,3-diaminopropanoic acid ligand have been synthesized? 
While the acid (2) was inactive, the corresponding ethyl 
ester (3) showed some activity. In an attempt to improve on 
the activity of the system and at the same time reduce its 
toxicity, we have established a method to synthesize some 
alternative esters of the compound. This paper reports on 
the preparation of the derivatives (4) and (5). 
Results and Discussion 
One method for the synthesis of ethyI2,3-diaminopropionate 
dihydrochloride (13) is to convert ethyl cyanoacetate (6) 
into the 2-hydroxyimino-derivative (7)3 followed by hydro-
genation with Adam's catalyst to afford (13).4 In order to 
obtain alternative ester derivatives, the hydroxyimino-ester 
(7) was transesterified using titanium tetra-isopropoxide in 
toluene containing an excess of the alcohol which is involved 
in the transesterification. 5 Ethanol was removed by azeotropic 
distillation with toluene, the volume of the latter solvent 
being kept constant by concurrent addition of more toluene. 
The transesterification of 7 was initially investigated with 
benzyl alcohol, the product (8) being obtained in a yield 
of51%. 
Transesterification was then accomplished with the alco-
hols, hexadecanol, cyclohexanol, and cholesterol, to form 
the related esters (9), (10), and (11) respectively, the yield of 
the latter (11) being much poorer than for the two former 
compounds. Amination of the ester could also be performed 
by this method to give rise to the amide (12). That such 
reactions had taken place was confirmed by lH n.m.r. 
spectrometry, the ethoxy-signals being replaced by those 
appropriate to the alcohol or amine concerned. 
Transesterification of the ester (7) was also attempted 
with the primary alcohols, 2,3-isopropylidene glycerol (17) 
and 1,2,3,4-di-isopropylidene galactose (18), but the products 
could not be fully characterized as they were never obtained 
pure. 
Subsequent hydrogenation of the two esters (9) and (10) 
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and the amide (12) was achieved in the presence of palladium 
on carbon and hydrochloric acid, the products formed being 
the diamino-dihydrochlorides (14), (15), and (16) respec-
tively. The appearance of the characteristic methylene and 
methine protons in the IH n.m.T. spectrum of each product 
confirmed the assignments. 
Of the three compounds (14), (15), and (16), attempts 
were made to convert only (14) and (15) into the platinum 
complexes (4) and (5), and each of these transformations 
?ccurred .satisfactorily with potassium tetrachloroplatinate 
In water, In the presence of aqueous sodium hydroxide. The 
free bases liberated from 14 and 15 in the presence of sodium 
hydroxide are, like 1 ,2-diaminoethane, not expected to be 
able to span trans-positions in square planar platinum(II), 
and mononuclear cis-complexes are therefore expected. 
That the cream-coloured products (4) and (5) were the cis-
~mp~unds was established by two strong infrared absorp-
tIOns In each case for the platinum -chlorine stretching 
frequencies (vPt-Cl). These appeared at 331 and 311 cm-1 
in the case of the hexadecyl ester (4), and at 327 and 310 cm -1 
for the cyclohexyl ester (5). To confirm the stereochemistry, 
the two platinum-nitrogen stretching frequencies were 
established through isotopic labelling of the amine hydrogens 
by deuterium exchange. These occurred at 426 cm-1 (406 
cm -1 on labelling) and 397 cm -1 (382 cm -Ion labelling) in 
the case of the hexadecyl ester (4). For the cyclohexyl ester 
~5), .the asymme~ric platinum-nitrogen stretching frequency 
IS hIdden by a lIgand band at 417 cm -1 and moves to 404 
cm-1 on labelling, while the symmetric platinum-nitrogen 
stretching frequency is at 386 cm-1 (367 cm-1 on labelling). 
In ~ddition to the cream products (4) and (5), derived by 
reactIon between (14) and (15) and potassium tetrachloro-
platinate, a purple compound was isolated from each 
reaction. Microanalytical data corresponded to those of 4 or 
5, thereby confirming the same ratio of metal to ligand. 
These could be either the dinuclear complex (19), in which 
coordination about platinum(II) is octahedral, or the salt 
[PtL2J [PtCI4 ] (20). The lower solubility compared with 4 or 
5 in, for instance, N,N-dimethylformamide, and the less 
intense infrared spectrum of the purple solid are consistent 
with both structures. 
Two platinum-nitrogen stretching frequencies are theo-
retically required for both possible structures. Two are 
observed at 423 and 401 cm-1 in the spectrum of the 
hexadecyl ester complex, whereas, in the cyclohexyl ester 
complex, the antisymmetric component is masked by a 
ligand band at 417 cm- 1 and the symmetric vibration gives 
rise to absorption at 387 cm -1. 
What establishes the structure of the purple solid as 20 
rather than 19 is the position of the single vPt-Cl band, 
which is .at 311 cm-1 [i.e. within the range 310-331 cm-1 
established for v Pt -CI in the four-coordinate complexes (4) 
and (5)]. Six-coordinate Ptll , as in 19, would yield much 
lower values of vPt-CI. The purple solid is therefore 
considered to be the salt [Pt~] [PtCI4 ]. Whether this is one 
of the two possible isomers (20a) or (20b) or a mixture of 
both cannot be decided by infrared spectroscopy, and the 
insolubility of the salt does not permit an n.m.T. study. The 
purple compounds were not further investigated. 
The two compounds (4) and (5) were tested by the US 
National Cancer Institute in the murine L1210 lymphoid 
leukemia system according to standard protocols.6 The 
hexadecyl analogue was found to be inactive (TIC 98-
S.-Afr. Tydskr. Chern., 1987,40(2) 
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107*) over a dose range of 3-200 mg kg-I, but the 
cyclohexyl analogue exhibited confirmed activity (TiC ;;::. 
125) at dose levels of 100 and 200 mg kg-I, with the optimal 
dose being 200 mg kg- 1 (TIC values of 260 and 180). The 
observed activity, however, does not match the potency 
exhibited by the clinically effective cisplatin. 
Experimental 
Unless otherwise stated, infrared spectra were obtained 
from Nujol mulls and n.m.T. spectra from solutions in 
deuteriochloroforrn with tetramethylsilane as internal 
reference. Where deuterium oxide was solvent, 3-(tri-
methylsilyl)propane sulphonic acid sodium salt was used as 
internal reference. Column chromatography was carried out 
on dry columns with Merck Kieselgel60 (70-230 mesh) as 
adsorbent. Light petroleum refers to the fraction of b.p. 
6O-80°C. The phrase 'residue obtained upon work-up' 
refers to the residue when the organic layer was separated, 
dried (MgS04), and the solvent evaporated under reduced 
pressure. 
Benzyl2-cyano-2-hydroxyiminoethanoate (8) 
The ester (7) (250 mg; 1,76 mmol) and benzyl alcohol 
(0,73 ml; 7,04 mmol) were dissolved in dry toluene (20ml). 
Titanium tetra-isopropoxide (0,02 ml) was added and the 
solution was boiled for 30 min. Any ethanol produced was 
removed by azeotropic distillation of toluene while further 
toluene was added at such a rate that the volume of the 
• T/ C is the ratio of the median survival of the treated mice (T) to that 
of the controls (C) expressed as a percentage, and is the basis for an 
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solution was kept constant. As the RF of the major 
component in the mixture was the same as starting material, 
boiling was continued overnight (16 h). The residue obtained 
upon work -up was chromatographed (eluent: 5 -10% ethyl 
acetate in light petroleum). Earlier fractions afforded a 
minor unidentified compound, followed in later fractions by 
the product (8) (184 mg; 51%), m.p. 107-108°C (from 
toluene) (Found: C, 58,8; H, 3,9; N, 13,7. Calc. for 
CIoHgNz0 3: C, 58,6; H, 4,0; N, 13,8%); vrnax 3270 (OH) 
and 1730 (C:O) cm-\ b 5,37 (2H, s, CHz), 7,2-7,55br 
(lH, s, OH), and 7,38 (5H, m, ArH); m/z 204 (M +, 1 %), 
187 (12), 143 (12),107 (80), and 91 (100). This product had 
the same RF as starting material. 
Hexadecyl 2-cyano-2-hydroxyiminoethanoate (9) 
The ester (7) (3,00 g; 0,021 mol) and hexadecanol (10,25 g; 
0,042 mol) in toluene (80 ml) containing titanium tetra-
isopropoxide (0,3 ml) was azeotropically distilled as above 
for 5 h and then boiled for 16 h. The residue obtained upon 
evaporation was chromatographed (eluent: 20-25% ethyl 
acetate in light petroleum). The major component gave the 
product (9) (3,62 g; 56%), m.p. 80-82°C (light petroleum) 
(Found: C, 67,6; H, 10,05; N, 8,4. Calc. forCI.JI34NZ03: C, 
67,45; H, 10,05; N, 8,3%); vrnax 3170 (OH) and 1733 (C:O) 
cm-\ b 0,80 (3H, t, J 6 Hz, CH3)' 1,15 (28H, sharp m, 
CHz), 4,36 (2H, t, J 6 Hz, OCHz), and 5,73br (lH, s, OH); 
m/z 321 (M+ -OH, 10%),294 (6), 110 (16), 97 (38), 69 
(62),57 (90), and 43 (100). 
CyclohexyI2-cyano-2-hydroxyiminoethanoate (10) 
The ester (7) (3,00 g; 0,021 mol) and cyclohexanol (4,5 ml, 
0,042 mol) in toluene (80 ml) containing the titanium 
alkoxide (0,3 ml) was distilled as above for 8 h, during which 
time the distillate (ca 100 ml) was collected. T.l.c. indicated 
some residual starting material, and the solution was boiled 
overnight (16 h). Distillation was repeated for a further 8 h. 
The residue obtained by evaporation was chromatographed 
(eluent: 40% ethyl acetate in light petroleum) to afford the 
product (10) (1,82 g; 44%), m.p. 99-100°C (from ether-
light petroleum) (Found: C, 55,3; H, 6,15; N, 14,1. Calc. for 
C.JI12NZ03: C, 55,1; H, 6,1; N, 14,3%); vrnax 3360 (OH), 
1728, and 1711 (C:O) cm-I; b 1,0-2,7 (1OH, m, CHz), 
5,13 (lH, m, CHO), and 9,60br (lH, s, OH); m/z 179 
(M+ -OH, 3%), 99 (11), 83 (55), and 82 (100). 
Cholest-5-en-3J3-yl 2-cyano-2-hydroxyiminoethanoate (11) 
The ester (7) (2,00 g; 0,0141 mol) and cholesterol (6,8 g; 
0,0176 mol) in toluene (80 ml) containing the titanium 
alkoxide (0,3 ml) was azeotropically distilled as above for 6 h 
and then boiled for 16 h. Distillation was repeated for a 
further 7 h. The residue obtained by evaporation was 
chromatographed (eluent: 30-50% ethyl acetate in light 
petroleum) to give the product (11) (1,35 g; 15%), m.p. 
165-167°C (from ether-light petroleum) (Found: C, 74,6; 
H, 9,45; N, 5,6. Calc. for ~oH46Nz03: C, 74,7; H, 9,55; N, 
5,8%); vrnax 3370 (OH), 1730, and 1719 (C:O) cm- I; b 
0,45-2,9 (43H, m, cholesteryl H), 4,93 (lH, m, CHO), 
5,60 (lH, m, C:CH), and 7,6Obr (lH, s, OH); m/z 482 (M +, 
3%),385 (42), and 368 (100). 
N-ButyI2-cyano-2-hydroxyiminoethanamide (12) 
The ester (7) (2,00 g; 0,014 mol) was dissolved in n-
butylamine (50 ml), titanium tetra-isopropoxide was added, 
151 
and the solution was boiled for 5 h. T.l.c. indicated no 
starting material. The solution was poured into water, which 
was acidified with dilute hydrochloric acid and extracted 
with ether (4 x 100 ml). The organic layer was washed with 
water and the residue obtained upon work-up afforded the 
product (12) (1,42 g; 60%), m.p. 122-124°C (from ether-
light petroleum) (Found: C, 49,5; H, 6,6; N, 24,6. Calc. for 
C7H IlN30 Z: C, 49,7; H, 6,5; N, 24,85%); vrnax 3378 (s), 
3210 and 3080 (OH and NH), and 1645 (C:O) cm-I; b 0,96 
(3H, distorted t, J 6 Hz, CH3)' 0,8-2,0 (4H, m, 2- and 3-
CHz), 3,2 (2H, q, J 6 Hz, 1-CHz), and 8,53 (lH, m, NH, 
slowly DzO exchangeable); m/z 170 (M+ + 1,9%), 169 
(M +,7), 152 (16), 126 (100), and 110 (37). 
HexadecyI2,3-diaminopropanoate dihydrochloride (14) 
The ester (9) (1,00 g; 2,95 mmol) was dissolved in absolute 
ethanol (60 mt) containing conc. hydrochloric acid (0,65 ml; 
6,5 mmol) and 10% palladium on carbon (0,2 g). The 
mixture was hydrogenated at a pressure of 4 atm. for 16 h. 
The reaction mixture was filtered, and the filtrate was 
concentrated and chilled in ice, whereupon crystallization of 
the product (14) occurred. Ethanol and a little water were 
added to the residue from the above filtration to dissolve 
product which was mixed with the catalyst. This was filtered 
hot, and the cooled filtrate was concentrated to afford more 
product, the combined yield being 0,71 g (60%). A small 
portion was recrystallized for analysis, m.p. 175-177°C 
decomp. (from ethanol) (Found: C, 57,0; H, 10,25; N, 7,0. 
Calc. for CI.JI4ZClzNzOz: C, 56,85; H, 10,5; N, 7,0%); vrnax 
1750 (C:O) cm- I; b 0,86 (3H, distorted t,J6Hz, CH3)' 1,22 
(28H, sharpm, CHz),3,30(2H,d,J6Hz,CHzN), 4,12 (2H, 
t, J 6 Hz, CHzO), and 4,23 (1H;, t, J 6 Hz, CHN). 
CyclohexyI2,3-diaminopropanoate dihydrochloride (15) 
The ester (10) (3,00 g; 15,3 mmol) was dissolved in absolute 
ethanol (100 ml) containing conc. hydrochloric acid (3,35 
ml; 33,5 mmol) and 10% palladium-charcoal (0,6 g). The 
mixture was hydrogenated at 4 atm. for 40 h. The reaction 
mixture was diluted with water and filtered hot. The filtrate 
was reduced in volume, chilled in ice, and filtered to yield 
the product (15) (2,05 g; 51 %), m.p. 211-215°C decomp. 
(Found: C, 41,7; H, 7,6; N, 10,75. Calc. for C;HzoClzNzOz: 
C, 41,7; H, 7,7; N, 10,8%); vrnax 1740 (C:O) cm-I; b (DzO) 
1,1-2,2 (1OH, m, CHz), 3,66 (2H, d, J 7 Hz, CHzN), 4,53 
(lH, t, J 7 Hz, CHN), and 4,92 (lH, m, CHO). 
N-Butyl 2,3-diaminopropanamide dihydrochloride (16) 
The amide (12) (250 mg; 1,48 mmol) was dissolved in 
absolute ethanol (35 ml) containing the above catalyst (100 
mg) and acid (0,35 ml; 3,5 mmol), and hydrogenated at 4 
atm. for 40 h. The reaction mixture was filtered and the 
filtrate evaporated to dryness. The crude material (250 mg) 
was recrystallized to give the product (16) (40 mg; 10%, 
yield not optimized), m.p. 188-19O°C (from methanol) 
(Found: C, 35,95; H, 8,1; N, 18,1. Calc. for ~HI9CI2N30: 
C, 36,2; H, 8,2; N, 18,1%); vrnax3340 (NH) and 1690 (C:O) 
cm-\ b (DMSO-d6 ) 0,88 (3H, distorted t, J 7 Hz, CH3), 
1,05-1,65 (4H, m, 2- and 3-CHz), 2,85-3,7 (4H, m, 
2 x CH2N), 4,23 (lH, t, J 6 Hz, CHN), and 8,25-9,35 
(7H,m,NH). 
Dichloro (hexadecyI2,3-diaminopropionato )platinum (II) (4) 










































in water (150 ml) was added to a solution of the ester (14) 
(1,20 g; 2,99 mmol) in ethanol (350 mI). A solution of 
sodium hydroxide (0,24 g; 6 mmol) in water (50 ml) was 
added dropwise with stirring over a period of 20 h 
(overnight). The resultant precipitate was collected by 
filtration and added to hot dimethylformamide. A purple 
precipitate formed and was removed by filtration, washed 
well with ethanol, and dried under vacuum over silica gel. 
On addition of water to the dimethylformamide solution, a 
yellow precipitate formed, which was collected by filtration, 
washed well with ethanol, and dried as above to give the cis-
complex (4) (1,12 g; 63%), m.p. 273°C decomp. (Found: C, 
38,65; H, 6,8; N, 4,8. Calc. for CIJI40CI2N202Pt: C, 38,4; 
H, 6,8; N, 4,7%); vrnax 1740 (C:O), 331(s) and 311(s) (cis 
Pt-Cl), and 426(w) and 397(w) (cis Pt-N) em-I. The 
purple precipitate was considered to be the salt (20, R = 
hexadecyl) (0,39 g; 22%), m. p. 235°C decomp. (Found: C, 
39,8;H, 7,O;N, 4,9. Calc. forCI9H40CI2N202Pt: C, 38,4; H, 
6,8; N, 4,7%); vrnax 1744 (C:O), 311(s) (trans Pt-CI), and 
423(w) and 401(w) (Pt-N) em-I. 
Dichloro( cyclohexyl 2,3-diaminopropionato )platinum(II) (5) 
A solution of potassium chloroplatinate (2,50 g; 6,02 mmol) 
in water (100 ml) was added to a solution of the ester (15) 
(1,56 g; 6,02 mmol) in aqueous ethanol (1:1; 150 ml). A 
solution of sodium hydroxide (0,48 g; 12 mmol) in water 
(50 ml) was added dropwise with stirring over a period of 
20 h. Work-up as above provided the cis-complex (5) 
(1,07 g; 39%), m.p. 325°C decomp. (Found: C, 24,1; H, 4,0; 
S.-Afr. Tydskr. Chern., 1987,40(2) 
N, 6,3. Calc. for CJIIsCI2N202Pt: C, 23,9; H, 4,0; N, 
6,2%); vrnax 1736 (C:O), 327(s) and 31O(s) (cis Pt-Cl), and 
417 (masked) and 386 (cis Pt-N) em-I. The purple pre-
cipitate was considered to be the salt (20, R = cyclohexyl) 
(0,91 g; 33%), m.p. 269°C decomp. (Found: C, 24,15; H, 
4,1; N, 6,2. Calc. for C9HISCI2N202Pt: C, 23,9; H, 4,0; N, 
6,2%); vrnax 1736 (C:O), 311(s) (trans Pt-CI), and 417 
(masked) and 387 (Pt-N) em-I. 
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